Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Condensed Statements of Operations (Unaudited)

v3.6.0.2
Condensed Consolidated Statements of Operations and Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 2,882,611 4,113,582 5,982,351 7,772,895
General and administrative 2,504,700 2,924,138 5,007,152 6,300,044
Loss before income taxes (5,387,311) (7,037,720) (10,989,503) (14,072,939)
Provision for income taxes 1,391 2,172
Net loss $ (5,387,311) $ (7,037,720) $ (10,990,894) $ (14,075,111)
Basic and diluted net loss per common share $ (0.27) $ (0.42) $ (0.57) $ (0.89)
Weighted average shares used in computing basic and diluted net loss per common share 19,733,015 16,761,586 19,376,998 15,794,970